IL6

interleukin 6

Details

HGNC: HGNC:6018
GeneCards: IL6
NCBI: 3569
Ensembl: ENSG00000136244
UniProt: P05231
OMIM: 147620
UCSC: uc064bxs.1
VEGA: OTTHUMG00000023178
ENA: M18403

Alias Symbols: IL-6, BSF2, HGF, HSF
Previous Symbols: IFNB2
Alias Names: "interferon, beta 2"
Previous Names: "interleukin 6 (interferon, beta 2)"

Associated Studies

SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis

2025 | Rostami-Afshari et al

Phenotype: ME/CFS, ME/CFS - CCC criteria, Post-exertional malaise (PEM)
Multifaceted evolution focused on maximal exploitation of domain knowledge for the consensus inference of Gene Regulatory Networks

2025 | Segura-Ortiz et al

Phenotype: ME/CFS, ME/CFS - CCC criteria, ME/CFS - ICC Criteria, Post-exertional malaise (PEM)
Phenotype: Fibromyalgia, Fibromyalgia - 1990 ACR (American College of Rheumatology) criteria, Fibromyalgia - 2011 ACR (American College of Rheumatology) criteria, ME/CFS, ME/CFS - CCC criteria, ME/CFS - ICC Criteria, Post-exertional malaise (PEM)
Phenotype: Fibromyalgia, Fibromyalgia - 1990 ACR (American College of Rheumatology) criteria, Fibromyalgia - 2011 ACR (American College of Rheumatology) criteria
The potential role of ocular and otolaryngological mucus proteins in myalgic encephalomyelitis/chronic fatigue syndrome

2024 | Huitsing et al

Phenotype: Female, ME/CFS
Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome

2024 | Saito et al

Phenotype: Long COVID, ME/CFS
Diverse immunological dysregulation, chronic inflammation, and impaired erythropoiesis in long COVID patients with chronic fatigue syndrome

2024 | Saito et al

Phenotype: Long COVID
Phenotype: Long COVID, ME/CFS, Post-exertional malaise (PEM)
Association of circulating biomarkers with illness severity measures differentiates myalgic encephalomyelitis/chronic fatigue syndrome and post-COVID-19 condition: a prospective pilot cohort study

2024 | Domingo et al

Phenotype: ME/CFS, ME/CFS - ICC Criteria, Post-exertional malaise (PEM)
The persistent viral infections in the development and severity of myalgic encephalomyelitis/chronic fatigue syndrome

2023 | Rasa-Dzelzkaleja et al

Phenotype: ME/CFS, ME/CFS - Fukuda criteria
Exploring the joint potential of inflammation, immunity, and receptor-based biomarkers for evaluating ME/CFS progression

2023 | Berkis et al

Phenotype: ME/CFS, ME/CFS - Fukuda criteria, ME/CFS - ICC Criteria, Post-exertional malaise (PEM)
Circulating miRNAs Expression in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

2023 | Soffritti et al

Phenotype: ME/CFS, ME/CFS - Fukuda criteria